Lesson plan
Pardoprunox
Pardoprunox (INN; code name SLV-308) is an antiparkinsonian drug developed by Solvay for the treatment of Parkinson's disease that reached phase III clinical trials before being discontinued. It was also being investigated for the treatment of [[major depression|depression] and anxiety but these indications appear to have been abandoned as well. Pardoprunox acts as a D 2 (pK i = 8.1) and D 3 receptor (pK i = 8.6) partial agonist (IA = 50% and 67%, respectively) and 5-HT 1A receptor (pK i = 8.5) full agonist (IA = 100%). It also binds to D 4 (pK i = 7.8), α 1 -adrenergic (pK i = 7.8), α 2 -adrenergic (pK i = 7.4), and 5-HT 7 receptors (pK i = 7.2) with lower affinity. Relative to other dopaminergic antiparkinsonian agents, pardoprunox is thought to have significantly less of a propensity for inducing certain side effects like dyskinesia and psychosis.
Article summary
Pardoprunox (INN; code name SLV-308) is an antiparkinsonian drug developed by Solvay for the treatment of Parkinson's disease that reached phase III clinical trials before being discontinued. It was also being investigated for the treatment of [[major depression|depression] and anxiety but these indications appear to have been abandoned as well. Pardoprunox acts as a D 2 (pK i = 8.1) and D 3 receptor (pK i = 8.6) partial agonist (IA = 50% and 67%, respectively) and 5-HT 1A receptor (pK i = 8.5) full agonist (IA = 100%). It also binds to D 4 (pK i = 7.8), α 1 -adrenergic (pK i = 7.8), α 2 -adrenergic (pK i = 7.4), and 5-HT 7 receptors (pK i = 7.2) with lower affinity. Relative to other dopaminergic antiparkinsonian agents, pardoprunox is thought to have significantly less of a propensity for inducing certain side effects like dyskinesia and psychosis.
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.